Swiss National Bank reduced its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 4.7% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,856,708 shares of the conglomerate’s stock after selling 92,500 shares during the quarter. Swiss National Bank owned about 0.26% of Danaher worth $368,111,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. WFA of San Diego LLC bought a new stake in shares of Danaher in the 2nd quarter valued at $26,000. Howard Hughes Medical Institute bought a new position in Danaher during the second quarter worth $27,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher in the third quarter worth $27,000. TruNorth Capital Management LLC acquired a new stake in Danaher in the third quarter worth $28,000. Finally, Tripletail Wealth Management LLC bought a new stake in Danaher in the third quarter valued at $31,000. 79.05% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the sale, the executive vice president directly owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 11.20% of the company’s stock.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on DHR
Danaher Trading Down 3.2%
Shares of Danaher stock opened at $195.60 on Monday. The stock has a fifty day simple moving average of $222.53 and a 200 day simple moving average of $215.99. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $242.80. The company has a market capitalization of $138.32 billion, a P/E ratio of 38.81, a price-to-earnings-growth ratio of 2.64 and a beta of 0.93. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.09. The business had revenue of $6.84 billion for the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business’s revenue was up 4.6% on a year-over-year basis. During the same period last year, the business earned $2.14 EPS. On average, sell-side analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.
Danaher Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, March 27th. This is an increase from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. Danaher’s payout ratio is 25.40%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
